Vertex Pharmaceuticals
S&P 500
Nasdaq 100
$515.44
+0.17%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Comfortable interest cover: operating profit covers interest about 313.8 times.
- Return on equity is healthy at 19.5%.
- Return on capital employed is healthy at 17.7%.
- Net profit margin is strong at 32.9%.
- Current assets comfortably cover current liabilities (current ratio 2.9).
!Watch-points
No notable watch-points flagged by the automated checks.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
13.53
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Piotroski F-ScoreModerate
5 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$130.64B
Current Price$ 515.44
High / Low$ 560.25 / 374.17
Stock P/E30.037296
Book Value$ 79.34
Dividend Yield0%
ROCE17.71%
ROE19.52%
Current Ratio2.90
P/B Ratio6.449369
EPS$ 15.32
PAT Margin32.94%
Cash PAT$4.16B
ICR313.78